MR

Mansukhbhai Ramjibhai Raiyani

Active Director Director DIN 03396136
DIN 03396136 First appointment Feb 2011 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Mansukhbhai Ramjibhai Raiyani

Data last updated:

Mansukhbhai Ramjibhai Raiyani is a Director at Panther Pharma Private Limited (since 2011). The company operates in Pharma.

DIN 03396136
Primary Designation Director
Industry Pharma
First Appointment 09 Feb 2011
Oldest Company Age 15 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Panther Pharma Private Limited U24230GJ2011PTC063978
Director09 Feb 20112011Active

Board colleagues of Mansukhbhai Ramjibhai Raiyani

Directorship timeline

Open interactive timeline →
Panther Pharma Private Limited
Premium access

Shareholding and investment profile for Mansukhbhai Ramjibhai Raiyani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mansukhbhai Ramjibhai Raiyani

Mansukhbhai Ramjibhai Raiyani currently holds 1 directorship: Panther Pharma Private Limited (Director, since 09 Feb 2011).

Mansukhbhai Ramjibhai Raiyani was first appointed on 09 Feb 2011 as Director at Panther Pharma Private Limited.

The current boards of Mansukhbhai Ramjibhai Raiyani's companies include Rameshbhai Odhavjibhai Savani (Panther Pharma Private Limited), Rameshbhai Ravjibhai Thummar (Panther Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available